Nanogels as Next Generation Drug Delivery Systems
Abstract
Nanogels are the innovative drug delivery systems which plays an integral part in pointing out many issues related to old and modern courses of treatment, such as nonspecific effects and poor stability. Nanogels are the highly cross linked nanosized hydrogels ranges from 20-200 nm. These can also be administered through various routes, including oral, pulmonary, nasal, parenteral, intraocular etc. Nanogels have high degree of drug loading capacity and it also shows better permeation capabilities due to a smaller size. These are also release the drug by pH responsive, thermosensitive, volume transition, photochemical internalization and photo-isomerization mechanism.Withemerging field of polymer sciences it has now become an inevitable to prepare smart nanosystems which can prove effective for treatment as well asclinical trials progress. The present review providing the comprehensive illustrations on novel applications, drug loading technique, mechanism of the drug release from nanogels. Further, current status, clinical trial status, and future perspective of the nanogels have been summarized.
Full Text:
PDFReferences
Dhawal D: Nanogels as novel and versatile pharmaceuticals. Int. J. Pharm. Pharm. Sci., 2012; 4: 67-74.
Bencherif SA, Siegwart DJ, Srinivasan A, Horkay F and Hollinger JO: Nanostructured hybrid hydrogels prepared by a combination of atom transfer radical polymerization and free radical polymerization. Biomaterials, 2009;30:5270-5278.
Soni G and Yadav KS: Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art. Saudi Pharm. J., 2016;24:133-139.
Tan JP, Tan MB and Tam MK: Application of nanogel systems in the administration of local anesthetics. Local and Regional Anesthesia 2010;3:93-100.
Rigogliusoa S, Sabatinob MA, Adamoa G, Grimaldib N, Dispenzab C: Nanogels: nanocarriers for drug delivery application. Chem. Eng. Trans., 2012;27:247-252.
Gonçalves C, Pereira P and Gama M: Self-assembled hydrogel nanoparticles for drug delivery applications. Materials, 2010; 3:1420-1460.
Kazakov S and Levon K: Liposome-nanogel structures for future pharmaceutical applications. Curr. Pharm. Des., 2006;12:4713-4728.
Sultana F, Manirujjaman, Md Imran-Ul-Haque, Arafat M and Sharmin S: An overview of nanogel drug delivery system. J. Appl. Pharm. Sci., 2013;3:95-105.
Vinogradov SV: Nanogels in the race for drug delivery. Nanomedicine, 2010;5:165-0168.
Singh N, Nisha, Gill V and Gill P: Nanogel based artificial chaperone technology: an overview. Am. J. Adv. Drug. Deliv., 2013; 1:271-276.
Lu X, Sun M and Barron AE: Non-ionic, thermo-responsive DEA/DMA nanogels: Synthesis, characterization, and use for DNA separations by microchip electrophoresis. J. Colloid Interface Sci., 2011;357: 345-353.
Fomina N, Sankaranarayanan J and Almutairi A: Photochemical mechanisms of light-triggered release from nanocarriers. Adv. Drug Deliv. Rev., 2012;64:1005-1020.
Patnaik S, Sharma AK, Garg BS, Gandhi RP and Gupta KC: Photoregulation of drug release in azo-dextran nanogels. Int. J. Pharm., 2007;342:184-193.
Labhasetwar V and Leslie-Pelecky DL: Biomedical applications of nanotechnology. John Wiley & Sons.2007.
Oh JK, Drumright R, Siegwart DJ and Matyjaszewski K: The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci., 2008;33:448-477.
Tang MD, Golden AP and Tien J: Molding of three-dimensional microstructures of gels. J. Am. Soc., 2003;125:12988-12989.
Ferreira SA, Coutinho PJG and Gama FM. Synthesis and characterization of self-assembled nanogels made of pullulan. Materials 2011;4:601-620.
Alles N, Soysa NS, Hussain MA, Tomomatsu N and Saito H: Polysaccharide nanogel delivery of a TNF-α and RANKL antagonist peptide allows systemic prevention of bone loss. Eur. J. Pharm. Sci., 2009;37:83-88.
Akiyoshi K: Nanogel-based materials for drug delivery system. Eur. Cells. Mater., 2007; 14:36-42.
Larsson M, Bergstrand, A, Mesiah, L, Vooren CV and Larsson SA: Nanocomposites of polyacrylic acid nanogels and biodegradable polyhydroxybutyrate for bone regeneration and drug delivery. J. Nanomater., 2014;1-9.
D Manry, D Gyawali and J Yang: Size optimization of biodegradable fluorescent nanogels for cell imaging. J. High Sch. Res., 2011;2:1-8
Lu A, Moatsou D, Longbottom DA and Reilly RK: Tuning the catalytic activity of L-proline functionalized hydrophobic nanogel particles in water. Chem. Sci., 2013;4:965-969.
Sanson N and Rieger J: Synthesis of nanogels/microgels by conventional and controlled radical crosslinking copolymerization. Polym. Chem., 2010;1:965-977.
Giulbudagian M, Yealland G and Honzke S: Breaking the barrier-potent anti-inflammatory activity following efficient topical delivery of etanercept using thermo-responsivenanogels. Theranostics, 2018;8(2):450-463,
Kohli E, Han HY, Zeman AD and Vinogradov SV: Formulation of biodegradable nanogel carriers with 5’-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activity. J. Control Release., 2007;121:19-27.
Park W, Park SJ, Na K. Potential of self-organizing nanogel with acetylated chondriotin sulfate as an-anti-cancer drug carrier. Colloids Surf B, 2010;79:501-508.
Singka GSL, Samah NA, Zulfakar MH, Yurdasipe A and Heard CM: Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur. J. Pharm. Biopharm., 2010;40:234-253.
Bae B and Na K: Self-quenching polysaccharide based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials, 2010;31:6325-6335.
Vinogradov SV, Zeman AD, Batrakova EV and Kabanov AV: Polyplexnanogel formulation for drug delivery of cytotoxic nucleoside analogs. J. Control Release., 2005;107:143-157.
Choi JH, Jang JY, Joung YK, Kwon MH and Park KD. Intracellular delivery and anti-cancer effect of assembled heparin-pluronicnanogel with RNase. J. Control Release., 2010;2:32-45.
Shimizu T, Kishida T, Hasegawa U, Ueda Y and Imanishi J: Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy. Biochem. Biophys. Res. Commun., 2008;367:330-335.
Bae KH, Mok H and Park TG: Synthesis, characterization and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials, 2008;29:3376-3383.
Park W, Kim KS, Bae B, Kim Y and Na K: Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur. J. Pharm. Sci., 2010;40:367-375.
Wu W, Aiello M, Zhou T, Bernila A and Banerjee P: In situ immobilization of quantum dots in polysaccharide based nanogel for integreation of optical pH sensing, tumor cell sensing and drug delivery. Biomaterials, 2010;31:3023-3031.
Wang Q, Xu H, Yang X and Yang Y: Drug release behavior from in situ gelatinized thermosensitive nanogel aqueous dispersions. Int. J. Pharm., 2008;361:189-193.
Ding YF, Li S and Liang L: Highly biocompatible chlorin e6-loaded chitosan nanoparticles for improved photodynamic cancer therapy. ACS Appl. Mater. Interfaces., 2018;10(12): 9980-9987.
Look M, Stern E, Wang QA, DiPlacido LD and Kashgarian M: Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. J. Clin. Investig., 2013; 123:1741-1749.
Wu W, Aiello M, Zhou T, Berliner A, Banerjee P and Zhou S: In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. Biomaterials, 2010;31:3023-3031.
Park W, Park S and Na K: Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier. Colloids Surf. B: Biointerfaces, 2010;79:501-508.
Peng J, Qi T and Liao J. Controlled release of cisplatin from pH-thermal dual responsive nanogels. Biomaterials, 2013; 34:8726-8740.
Arunraj TR, Sanoj N, Rejinold N, Ashwin K and Jayakumar R: Bio-responsive chitin-poly (L-lactic acid) composite nanogels for liver cancer. Colloids Surf. B: Biointerfaces, 2014;113:394-402.
Abd El-Rehim HA, Swilem AE, Klingner A, Hegazy ESA and Hamed AA: Developing the potential ophthalmic applications of pilocarpine entrapped into polyvinylpyrrolidone–poly (acrylic acid) nanogel dispersions prepared by γ radiation. Biomacromolecules, 2013;14:688–698,.
Derfus AM, Chan WCW and Bhatia SN: Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv. Mater., 2004;16:961-966.
Desale SS, Raja SM and Kim JO: Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models. J. Control Release., 2015;208:59-66.
Chen W, Achazi K, Schade B and Haag R: Charge-conversional and reduction-sensitive poly (vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release. . J. Control Release., 2015;205:15-24.
Zhao L, Xiao C and Ding J: Competitive binding-accelerated insulin release from a polypeptide nanogel for potential therapy of diabetes. Poly. Chem., 2015; 6:3807-3815.
Malzahn K, Jamieson WD, Droge M, Mailander V and Jenkins ATA: Advanced dextran based nanogels for fighting Staphylococcus aureus infections by sustained zinc release. J. Mat. Chem B., 2014;2:2175-2183.
Moya-Ortega MD, Alves TF, Alvarez-Lorenzo C, Concheiro A and Stefansson E: Dexamethasone eye drops containing γ-Cyclodextrin based nanogel. Int. J. Pharm., 2013;441: 507-515.
Abd El-Rehim HA1, Swilem AE, Klingner A, HegazySA and Hamed AA: Developing the potential ophthalmic applications of pilocarpine entrapped into polyvinylpyrrolidone-poly[acrylicacid] nanogel dispersions prepared by γ radiation. Biomacromolecules, 2013;14: 688-698.
Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A and Loftsson T: Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int. J. Pharm., 2012;428:152–163.
Zhao L, Xiao C and Ding J: Competitive binding-accelerated insulin release from a polypeptide nanogel for potential therapy of diabetes. Poly. Chem., 2015; 6:3807-3815.
Mohammad SM and Turney PD: NRC Emotion Lexicon. National Research Council, Canada, 2013.
Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A and Mittal G: Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention. Drug Deliv., 2013;20:306-309.
Redis RS, Sieuwerts AM and Look MP: CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget, 2013;10:1748-1762.
Otomo K, Koga T and Mizui M: Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice. J. Immunol. Res., 2015;95:5533-5537.
Abd El-Rehim HA, Swilem AE, Klingner A, Hegazy SA and Hamed AA: Developing the potential ophthalmic applications of pilocarpine entrapped into polyvinylpyrrolidone-poly(acrylic acid) nanogel dispersions prepared by γ radiation. Biomacromolecules, 2013; 14: 688-698.
Refbacks
- There are currently no refbacks.
